You can't accuse CMS of shying away from a fight.
A proposed rule on changes to Medicare Part D is bound to trigger a lot of feedback for the Centers...
So That's What "Non-Interference" Means: CMS Defines Loaded Term in Proposed Part D Rule
The 700-page Part D proposed rule does much more than change the "protected" class list. Among many other provisions, it spells out how CMS interprets the infamous "non-interference" clause.
More from Medicare
• By
Industry experts forecast the impact of President Trump's Most-Favored Nation drug pricing policy on the commercial insurance industry.
• By
The plan could curtail a period of pricing flexibility for newer subcutaneous versions of important oncology drugs.
• By
CMS Administrator Mehmet Oz said PBMs may deserve "one last chance" to fix the rebate system before federal regulations and legislation are enacted.
• By
Companies with significant exposure to Medicare and Medicaid have fewer options for passing along higher costs to consumers because of price controls in the programs.
More from Government Payers
• By
CMS Administrator Mehmet Oz said PBMs may deserve "one last chance" to fix the rebate system before federal regulations and legislation are enacted.
• By
The list of essential prescription drugs and related products will shape Canada’s first national formulary for the country’s universal pharmacare program.
• By
Incentives for repurposed drugs proposed as part of the EU pharma reform package are a “great step forward,” but more recognition is needed from payers and regulators to leverage the benefits of these medicines, experts say.